Integris Medtech Limited

Market Risk

There is no assurance of an active market for the shares post-listing.

Financial · high

Regulatory Risk

Delay or failure in obtaining, renewing, or maintaining key regulatory approvals may restrict the company's ability to market and sell products.

Operational · high

Acquisition Risk

Business model relies significantly on acquisitions, which may expose the company to integration, execution, and value realization risks.

Operational · high

Quality Risk

Self-corrective quality issues related to product holds and recalls may result in operational disruption, financial loss, and reputational harm.

Operational · high

Competition Risk

Intense competition and pricing pressure may adversely affect market share, profitability, and future growth.

Market · high